251 related articles for article (PubMed ID: 15730730)
41. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
42. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
43. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease.
Richter K; Holz O; Jörres RA; Mücke M; Magnussen H
Eur Respir J; 1999 Sep; 14(3):697-701. PubMed ID: 10543295
[TBL] [Abstract][Full Text] [Related]
44. Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):464-70. PubMed ID: 20568377
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine.
Barczyk A; Pierzchala W; Sozañska E
Respir Med; 2003 Jun; 97(6):726-33. PubMed ID: 12814161
[TBL] [Abstract][Full Text] [Related]
46. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease.
Yoshikawa T; Dent G; Ward J; Angco G; Nong G; Nomura N; Hirata K; Djukanovic R
Am J Respir Crit Care Med; 2007 Mar; 175(5):473-9. PubMed ID: 17110644
[TBL] [Abstract][Full Text] [Related]
47. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
Culpitt SV; Maziak W; Loukidis S; Nightingale JA; Matthews JL; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133
[TBL] [Abstract][Full Text] [Related]
48. IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.
Chen JH; Qin L; Shi YY; Feng JT; Zheng YL; Wan YF; Xu CQ; Yang XM; Hu CP
Respir Med; 2016 Dec; 121():48-58. PubMed ID: 27888992
[TBL] [Abstract][Full Text] [Related]
49. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
50. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
Peng H; Chen P; Cai S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
[TBL] [Abstract][Full Text] [Related]
51. IL-2 and IL-10 levels in induced sputum and serum samples of asthmatics.
Ceyhan BB; Enc FY; Sahin S
J Investig Allergol Clin Immunol; 2004; 14(1):80-5. PubMed ID: 15160446
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines.
Schmidt-Ioanas M; Pletz MW; de Roux A; Lode H
Respir Med; 2006 Apr; 100(4):639-47. PubMed ID: 16199149
[TBL] [Abstract][Full Text] [Related]
54. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease.
Fujimoto K; Yasuo M; Urushibata K; Hanaoka M; Koizumi T; Kubo K
Eur Respir J; 2005 Apr; 25(4):640-6. PubMed ID: 15802337
[TBL] [Abstract][Full Text] [Related]
55. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
56. [The levels of nerve growth factor and IL-4 in induced sputum and characteristics of airway inflammation in cough variant asthma].
Peng QF; Kong LF
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):221-4. PubMed ID: 21600086
[TBL] [Abstract][Full Text] [Related]
57. Value of sputum differential count in chronic obstructive airway disease.
Neopane A; Sharma L; Dulal S; Panta S
J Nepal Health Res Counc; 2013 Jan; 11(23):26-9. PubMed ID: 23787521
[TBL] [Abstract][Full Text] [Related]
58. Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma.
Rovina N; Dima E; Bakakos P; Tseliou E; Kontogianni K; Papiris S; Koutsoukou A; Koulouris NG; Loukides S
Respir Med; 2015 May; 109(5):580-7. PubMed ID: 25840484
[TBL] [Abstract][Full Text] [Related]
59. Induced sputum eicosanoid concentrations in asthma.
Pavord ID; Ward R; Woltmann G; Wardlaw AJ; Sheller JR; Dworski R
Am J Respir Crit Care Med; 1999 Dec; 160(6):1905-9. PubMed ID: 10588604
[TBL] [Abstract][Full Text] [Related]
60. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
Bhowmik A; Seemungal TA; Sapsford RJ; Wedzicha JA
Thorax; 2000 Feb; 55(2):114-20. PubMed ID: 10639527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
